Empagliflozin vs placebo was associated with greater reductions in risk for cardiovascular disease among patients with type 1 diabetes. Sodium–glucose cotransporter inhibitors (SGLTis) are ...

The aetiology of T1D is largely unknown, but it is thought that a genetic predisposition, environmental factors and distinctive metabolic changes are involved in the initiation, development and ...

People with LADA follow similar T1D practices with insulin, eating, exercise, and blood sugar management. Type 1.5 diabetes is commonly known as LADA, or latent autoimmune diabetes in adults.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Islet transplantation offered significant benefits in reducing mortality and other complications in patients with type 1 diabetes (T1D) over a median follow-up duration exceeding 10 years.

In T1D, the immune system mistakenly attacks and ... Education and Support: Understanding the disease, including recognising signs of hypo- and hyperglycemia, is crucial for effective management.

The University of Bristol's Diabetes and Metabolism Research Group is conducting the T1D-DAB study to explore how age and ethnicity affect the development of Type 1 Diabetes. We know a lot about Type ...

Founded in 1970 by families whose loved ones had been diagnosed with type 1 diabetes (T1D), Breakthrough T1D, formerly JDRF, is a tax-exempt nonprofit 501(c)3 organization, opening doors that ...

TORONTO, May 01, 2025 (GLOBE NEWSWIRE) -- Beginning May 3, 2025, Matt Varey, retired banking executive, Vice Chair of Breakthrough T1D’s International Board, Board Member of Breakthrough T1D ...